Objective: Persistent stress and life events affect the course of ulcerative colitis and irritable bowel syndrome by largely unknown mechanisms. Corticotropin-releasing hormone (CRH) has been ...

PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce that it was selected by Neurocrine Biosciences, Inc. for the ...

PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to ...

Researchers have uncovered a brain mechanism in the prefrontal cortex that determines how animals respond to others’ emotions ...

The US Food and Drug Administration has approved crinecerfont for treating congenital CAH in combination with glucocorticoids ...

The FDA approved crinecerfont (Crenessity) as a first-in-class treatment for classic congenital adrenal hyperplasia (CAH), ...

Neurocrine Biosciences’ US FDA approved crinecerfont is available for children and adults to treat classic congenital adrenal hyperplasia: San Diego Tuesday, December 24, 2024, ...

After seven decades with no advances in the treatment of the genetic disorder classic congenital adrenal hyperplasia (CAH), ...

Neurocrine Biosciences' CEO, Kyle W. Gano, Ph.D., emphasized the significance of Crenessity, stating that it provides a ...

The approval was based on phase 3 data from the randomized, double-blind, placebo-controlled CAHtalyst adult study and ...

研究为理解创伤后应激障碍（PTSD）、自闭症和精神分裂症等疾病提供了新的见解。识别调节共鸣反应的特定大脑机制可以帮助临床研究开发新的靶向疗法，也能够帮助改善在各种精神状况中观察到的异常情绪反应。